Skip to content

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III

Inflammatory Response and Anti-inflammatory Action for Aortopathy & Arteriopathy (5A-Plan): A Multicenter Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04918108
Enrollment
2000
Registered
2021-06-08
Start date
2021-01-01
Completion date
2021-08-30
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Dissection

Keywords

Aortic Dissection, Inflammatory Response

Brief summary

Anatomopathological classifications have been well identified in aortic dissection with important therapeutic implications. The authors evaluated the inflammatory response in patients with aortic dissection (AD) and assessed the presence of distinct inflammatory subphenotypes within this disease.

Interventions

BIOLOGICALinflammatory response

laboratory data (leukocyte, neutrophils, monocyte, lymphocytes, platelet, fibrinogen, D-dimer, neutrophils-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio)

Sponsors

The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Beijing Anzhen Hospital
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
First Affiliated Hospital of Shantou University Medical College
CollaboratorOTHER
The First Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
TEDA International Cardiovascular Hospital
CollaboratorOTHER
Xiamen Cardiovascular Hospital
CollaboratorUNKNOWN
Shanghai East Hospital Tongji University
CollaboratorUNKNOWN
Tianjin Chest Hospital, Tianjin Medical University
CollaboratorUNKNOWN
Nanjing First Hospital, Nanjing Medical University
CollaboratorOTHER
Xiangya Hospital of Central South University
CollaboratorOTHER
The First Affiliated Hospital of Bengbu Medical University
CollaboratorOTHER
Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* acute type Aortic dissection;

Exclusion criteria

* Iatrogenic aortic dissection OR traumatic aortic dissection * Patients with hematological diseases, infectious diseases, malignant tumors, immune system diseases, or severe liver diseases. * Preoperative use of mechanical ventilation, blood transfusion, renal replacement therapy, extracorporeal membrane oxygenation, or intra-aortic balloon pump during the current admission.

Design outcomes

Primary

MeasureTime frameDescription
30-day mortality30 days after surgeryany cause death within 30 days of surgery

Secondary

MeasureTime frameDescription
ICU mortality7 days after surgeryany cause death within ICU

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026